Metabolic syndrome and other cardiovascular risk factors are highly prevalent in people with
schizophrenia. Patients are at risk for premature mortality and overall have limited access to …

BackgroundDespite increased cardiometabolic risk in individuals with mental illness taking
antipsychotic medication, metabolic screening practices are often incomplete or …

The lifespan of people with severe mental illness (SMI) is shorter compared to the general
population. This excess mortality is mainly due to physical illness. We report prevalence …

Physical disorders are, compared to the general population, more prevalent in people with
severe mental illness (SMI). Although this excess morbidity and mortality is largely due to …

People with severe mental illnesses, such as schizophrenia, depression or bipolar disorder,
have worse physical health and reduced life expectancy compared to the general …

Excess deaths from cardiovascular disease are a major contributor to the significant
reduction in life expectancy experienced by people with schizophrenia. Important risk factors …

Objective Recent reports suggest that the mortality gap between persons with schizophrenia
and the general population is increasing. We investigated the mortality, age at death, and …

Over the last five years, large data sets on mortality in schizophrenia have been published
which have established mortality as a measurable clinical endpoint. Four issues need …

The current review outlines the under-appreciated effects of physical exercise on the course
of psychiatric disorders, focussing on recent findings from animal and human research …

BackgroundMetabolic and cardiovascular health problems have become a major focus for
clinical care and research in schizophrenia. AimsTo evaluate the content and quality of …